Back to search

Article

Palbociclib induces the apoptosis of lung squamous cell carcinoma cells via Rb-independent STAT3 phosphorylation

2022-06-14

Abstract excerpt

<title>Abstract</title> <p>Lung squamous cell carcinoma (LUSC) treatment response is poor and treatment alternatives are limited. Palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor, has recently been approved for hormone receptor-positive breast cancer patients and applied in multiple preclinical models, but its use for LUSC therapy remains elusive. Here, we investigated whether palbociclib induced cell a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f9978c3b-3af0-5a8e-b563-c7ecf70a6901
DOI
10.21203/rs.3.rs-1733404/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Palbociclib induces the apoptosis of lung squamous cell carcinoma cells via Rb-independent STAT3 phosphorylationDOI 10.21203/rs.3.rs-1733404/v1
Select a neighboring publication to make it the new centre.